Heterogeneity of angiogenesis and blood vessel maturation in human tumors: Implications for antiangiogenic tumor therapies

Cancer Research

Volumn 60, Issue 5, 2000, Pages 1388-1393

  Eberhard, Anne ^a   Kahlert, Sebastian ^a   Goede, Valentin ^a   Hemmerlein, Bernhard ^a   Plate, Karl H ^b   Augustin, Hellmut G ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

^b UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS; ARTICLE; CELL HETEROGENEITY; CELL PROLIFERATION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); PERICYTE; PRIORITY JOURNAL; SCORING SYSTEM;

ANIMALS; ANTINEOPLASTIC AGENTS; CATTLE; CELL DIFFERENTIATION; CELL DIVISION; ENDOTHELIUM, VASCULAR; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; PERICYTES;

EID: 0034161989     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Folkman, J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med., 1: 27-31, 1995.
2. Pluda, J. M. Tumor-associated angiogenesis: mechanisms, clinical implications, and therapeutic strategies. Semin. Oncol., 24: 203-221, 1997.
3. Jones. A., and Harris, A. L. New developments in angiogenesis: a major mechanism for tumor growth and target for therapy. Cancer J. Sci. Am., 4: 209-217, 1998.
4. Augustin, H. G. Antiangiogenic tumour therapy: will it work? Trends Pharmacol. Sci., 19: 216-222, 1998.
5. Folkman, J. Fighting cancer by attacking its blood supply. Sci. Am., 275:150-154, 1996.
6. Harris, A. L. Antiangiogenesis for cancer therapy. Lancet, 349 (Suppl. 2): 13-15, 1997.
7. Boehm, T., Folkman, J., Browder, T., and O'Reilly, M. S. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance. Nature (Lond.), 390: 404-407, 1997.
8. Risau, W. Mechanisms of angiogenesis. Nature (Lond.), 386: 671-674, 1997.
9. Hanahan, D. Signaling vascular morphogenesis and maintenance. Science (Washington DC), 277: 48-50, 1997.
10. Beck, L., Jr., and D'Amore, P. A. Vascular development: cellular and molecular regulation. FASEB J., 11: 365-373, 1997.
11. Denekamp, J. Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy. Br. J. Radiol., 66: 181-196, 1993.
12. Hobson, B., and Denekamp, J. Endothelial proliferation in tumours and normal tissues: continuous labelling studies. Br. J. Cancer, 49: 405-413, 1984.
13. Vartanian, R. K., and Weidner, N. Endothelial cell proliferation in prostatic carcinoma and prostatic hyperplasia: correlation with Gleason's score, microvessel density, and epithelial cell proliferation. Lab. Investig., 73: 844-850, 1995.
14. Fox, S. B., Gatter, K. C., Bicknell, R., Going, J. J., Stanton, P., Cooke, T. G., and Harris. A. L. Relationship of endothelial cell proliferation to tumor vascularity in human breast cancer. Cancer Res., 53: 4161-4163, 1993.
15. Vartanian, R. K., and Weidner, N. Correlation of intratumoral endothelial cell proliferation with microvessel density (tumor angiogenesis) and tumor cell proliferation in breast carcinoma. Am. J. Pathol., 144: 1188-1194, 1994.
16. Vermeulen, P. B., Verhoeven, D., Hubens, G., Van Maeck, E., Goovaerst, G., Huyghe, M., De Bruijn, E. A., Van Oosterom, A. T., and Dirix, L. Y. Microvessel dcnsily, endothelial cell proliferation and tumour cell proliferation in human colorectal adenocarcinomas. Ann. Oncol., 6: 59-64, 1995.
17. Brem, S., Cotran, R., and Folkman, J. Tumor angiogenesis: a quantitative method for histologic grading. J. Natl. Cancer Inst., 48: 347-356, 1992.
18. Weidner, N. Tumoural vascularity as a prognostic factor in cancer patients: the evidence continues to grow. J. Pathol., 184: 119-122, 1998.
19. Fox, S. B. Tumour angiogenesis and prognosis. Histopathology, 30: 294-301, 1997.
20. Augustin, H. G., Braun, K., Telemenakis, I., Modlich, U., and Kuhn, W. Ovarian angiogenesis. Phenotypic characterization of endothelial cells in a physiological model of blood vessel growth and regression. Am. J, Pathol., 147: 339-351, 1995.
21. Goede, V., Schmidt, T., Kimmina, S., Kozian, D., and Augustin, H. G. Analysis of blood vessel maturation processes during cyclic ovarian angiogenesis. Lab. Investig., 78: 1385-1394, 1998.
22. Jones, A. S., Roland, N. J., Caslin, A. W., Cooke, T. G., Cooke, L. D., and Forster, G. A comparison of cellular proliferation markers in squamous cell carcinoma of the head and neck. J. Laryngol. Otol., 108: 859-864, 1994.
23. Terada, T., Ohta, T., Kitamura, Y., Ashida, K., and Matsunaga, Y. Cell proliferative activity in intraductal papillary-mucinous neoplasms and invasive ductal adenocarcinomas of the pancreas: an immunohistochemical study. Arch. Pathol. Lab. Med., 122: 42-46, 1998.
24. Redmer, D. A., and Reynolds, L. P. Angiogenesis in the ovary. Rev. Reprod., 1: 182-192, 1996.
25. Mauceri, H. J., Hanna, N. N., Beckett, M. A., Gorski, D. H., Staba, M. J., Stellato, K. A., Bigelow, K., Heimann, R., Gately, S., Dhanabal, M., Soff, G. A., Sukhatme, V. P., Kufe, D. W., and Weichselbaum, R. R. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature (Lond.), 394: 287-291, 1998.
26. v integrins. Science (Washington DC), 270: 1500-1502, 1995.
27. Ferrara, N., Chen, H., Davis Smyth, T., Gerber, H. P., Nguyen, T. N., Peers, D., Chisholm, V., Hillan, K. J., and Schwall, R. H. Vascular endothelial growth factor is essential for corpus luteum angiogenesis Nat. Med., 4: 336-340, 1998.
28. Pezzella, F., Paslorino, U., Tagliabuc, E., Andreola, S., Sozzi, G., Gasparini, G., Menard, S., Gaiter, K. C., Harris, A. L. Fox, S., Buyse. M., Pilotti, S., Pierotti, M., and Rilke, F. Non-small-cell lung carcinoma tumor growth without morphological evidence of neo-angiogenesis. Am. J. Pathol., 151: 1417-1423, 1997.
29. Maniotis, A. J., Folberg, R., Hess, A., Seftor, E. A., Gardner, L. M., Pe'er, J., Trent, J. M., Meltzer, P. S., and Hendrix, M. J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol., 155: 739-752, 1999.
30. Kumar, S., Ghellal, A., Li, C., Byrne, G., Haboubi, N., Wang, J. M., and Bundred, N. Breast carcinoma: vascular density determined using CD105 antibody correlates with tumor prognosis. Cancer Res., 59: 856-861, 1999.
31. 3: a new prognostic indicator in breast cancer. Clin. Cancer Res., 4: 2625-2634, 1998.
32. Risau, W. Differentiation of endothelium. FASEB J., 9: 926-933, 1995.
33. Meyer, G. T., and McGeachie, J. K. Angiogenesis in the developing corpus luteum of pregnant rals: a stereologic and autoradiographic study. Anal. Rec., 222: 18-25, 1988.
34. Rodger, F. E., Young, F. M., Fraser, H. M., and Illingworth, P. J. Endothelial cell proliferation follows the mid-cycle luteinizing hormone surge, but not human chorionic gonadotrophin rescue, in the human corpus luteum. Hum. Reprod., 12: 1723-1729, 1997.
35. Davis, S., Aldrich, T. H., Jones, P. F., Acheson, A., Compton, D. L., Jain, V., Ryan, T. E., Bruno, J., Radziejewski, C., Maisonpierre, P. C., and Yancopoulos, G. D. Isolation of angiopoietin-1, a ligand for the TIE2 receptor, by secretion-trap expression cloning. Cell, 87: 1161-1169, 1996.
36. Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., DaLy, T. J., Davis, S., Sato, T. N., and Yancopoulos, G. D. Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science (Washington DC). 277: 55-60, 1997.
37. Lauren, J., Gunji, Y., and Alitalo, K. Is angiopoietin-2 necessary for the initiation of tumor angiogenesis? Am. J. Pathol., 15.1: 1333-1339, 1998.
38. Lindahl, P., Hellstrom, M., Kalen, M., and Betshollz, C. Endothelial-perivascular cell signaling in vascular development: lessons from knockout mice. Curr. Opin. Lipidol., 9: 407-411, 1998.
39. Lindahl, P., Johansson, B. R., Leveen, P., and Belsholtz, C. Pericyte loss and microaneurysm formation in PDGF-β-deficient mice. Science (Washington DC), 277: 242-245, 1997.
40. Dvorak, H. F. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N. Engl. J. Med., 315: 1650-1659, 1986.
41. Konerding, M. A., Miodonski, A. J., and Lametschwandtner, A. Microvascular corrosion casting in the study of tumor vascularity: a review. Scanning Microsc., 9: 1233-1244, 1995.
42. Benjamin, L. E., Golijanin, D.. Itin, A., Pode, D., and Keshet, E. Selective ablation of immature blood vessels in established human tumors follows vascular endothelial growth factor withdrawal. J. Clin. Investig., 103: 159-165, 1999.
43. Benjamin, L. E., Hemo, I., and Keshet, E. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-β; and VEGF. Development (Camb.), 125: 1591-1598, 1998.